Induction of protective immunity against Japanese encephalitis in mice by immunization with a plasmid encoding Japanese encephalitis virus premembrane and envelope genes

被引:101
作者
Konishi, E
Yamaoka, M
Khin-Sane-Win
Kurane, I
Mason, PW
机构
[1] Kobe Univ, Sch Med, Dept Hlth Sci, Suma Ku, Kobe, Hyogo 65401, Japan
[2] Kobe Univ, Sch Med, Dept Med Zool, Kobe, Hyogo 650, Japan
[3] Kinki Univ, Sch Med, Dept Microbiol, Osaka 589, Japan
[4] USDA ARS, Plum Isl Anim Dis Ctr, Greenport, NY 11944 USA
关键词
D O I
10.1128/JVI.72.6.4925-4930.1998
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A DNA vaccine plasmid containing the Japanese encephalitis (JE) virus premembrane (prM) and envelope (E) genes (designated pcDNA3JEME) was evaluated for immunogenicity and protective efficacy in mice. Two immunizations of 4-week-old female ICR mice with pcDNA3JEME by intramuscular or intradermal injections at a dose of 10 or 100 mu g per mouse elicited neutralizing (NEUT) antibodies at titers of 1:10 to 1:20 (90% plaque reduction), and all immunized mice survived a challenge with 10,000 50% lethal doses of the P3 strain of JE virus. A single immunization with 100 mu g of pcDNA3JEME did not elicit detectable NEUT antibodies but induced protective immunity. Spleen cells obtained from BALB/c mice immunized once with 10 or 100 mu g of pcDNA3JEME contained JE virus-specific memory cytotoxic T lymphocytes (CTLs). BALB/c mice maintained detectable levels of memory B cells and CTLs for at least 6 months after one immunization with pcDNA3JEME at a dose of 100 mu g. The CTLs induced in BALB/c mice immunized twice with 100 mu g of pcDNA3JEME were CD8 positive and recognized mainly the envelope protein. These results indicate that pcDNA3JEME has the ability to induce a protective immune response which includes JE virus-specific antibodies and CTLs.
引用
收藏
页码:4925 / 4930
页数:6
相关论文
共 36 条
[1]   SYNTHESIS AND SECRETION OF RECOMBINANT TICK-BORNE ENCEPHALITIS-VIRUS PROTEIN-E IN SOLUBLE AND PARTICULATE FORM [J].
ALLISON, SL ;
STADLER, K ;
MANDL, CW ;
KUNZ, C ;
HEINZ, FX .
JOURNAL OF VIROLOGY, 1995, 69 (09) :5816-5820
[2]   SAFETY OF AND IMMUNOLOGICAL RESPONSE TO A RECOMBINANT VACCINIA VIRUS-VACCINE EXPRESSING HIV ENVELOPE GLYCOPROTEIN [J].
COONEY, EL ;
COLLIER, AC ;
GREENBERG, PD ;
COOMBS, RW ;
ZARLING, J ;
ARDITTI, DE ;
HOFFMAN, MC ;
HU, SL ;
COREY, L .
LANCET, 1991, 337 (8741) :567-572
[3]   IMMUNIZATION WITH DNA [J].
DONNELLY, JJ ;
ULMER, JB ;
LIU, MA .
JOURNAL OF IMMUNOLOGICAL METHODS, 1994, 176 (02) :145-152
[4]   RECOMBINANT VACCINIA VIRUSES CO-EXPRESSING DENGUE-1 GLYCOPROTEINS PRM AND E-INDUCE NEUTRALIZING ANTIBODIES IN MICE [J].
FONSECA, BAL ;
PINCUS, S ;
SHOPE, RE ;
PAOLETTI, E ;
MASON, PW .
VACCINE, 1994, 12 (03) :279-285
[5]   Identification of two epitopes on the dengue 4 virus capsid protein recognized by a serotype-specific and a panel of serotype-cross-reactive human CD4(+) cytotoxic T-Lymphocyte clones [J].
Gagnon, SJ ;
Zeng, WL ;
Kurane, I ;
Ennis, FA .
JOURNAL OF VIROLOGY, 1996, 70 (01) :141-147
[6]  
Germain Ronald N., 1993, P629
[7]   SYNERGISTIC INTERACTIONS OF ANTI-NS1 MONOCLONAL-ANTIBODIES PROTECT PASSIVELY IMMUNIZED MICE FROM LETHAL CHALLENGE WITH DENGUE-2 VIRUS [J].
HENCHAL, EA ;
HENCHAL, LS ;
SCHLESINGER, JJ .
JOURNAL OF GENERAL VIROLOGY, 1988, 69 :2101-2107
[8]  
JOHNSON MP, 1988, VACCINES, V88, P189
[9]   Different roles for cytotoxic T cells in the control of infections with cytopathic versus noncytopathic viruses [J].
Kagi, D ;
Hengartner, H .
CURRENT OPINION IN IMMUNOLOGY, 1996, 8 (04) :472-477
[10]   MONOCLONAL-ANTIBODIES FOR DENGUE VIRUS PRM GLYCOPROTEIN PROTECT MICE AGAINST LETHAL DENGUE INFECTION [J].
KAUFMAN, BM ;
SUMMERS, PL ;
DUBOIS, DR ;
COHEN, WH ;
GENTRY, MK ;
TIMCHAK, RL ;
BURKE, DS ;
ECKELS, KH .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1989, 41 (05) :576-580